Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE +0.09%, DAX +0.72%, CAC40 +0.21%

Jun 30 ,2026

  • Synopsis

    • European equity markets set for a higher open. Asian equities mixed and US futures slightly higher post positive close overnight. JGB curve bear steepening while Treasuries unchanged. Australian yields lower following RBA minutes. Crude pulling back from earlier highs. Gold and silver under some pressure. Dollar firming against other currencies, yen at 40-year low. Bitcoin fluctuating around $60K.

    • On the agenda for today, a number of central banks speakers participate in various events; featuring, Bank of Spain's Salido, BOE's Breeden, ECB's Vujcic, Lane, Elderson, Schnabel and Cipollone. In politics, UK's long-awaited defense investment plan to be published; the plan includes £5B worth of investment to increase armed forces' use of drones and autonomous weapons, according to Ministry of Defence.

    • Amidst busy macro calendar, UK Q1 final GDP and Jun house price index, Germany May retail sales due at 7:00 BST, followed by France Jun prelim CPI, May consumer goods spending and PPI at 7:45 BST. Switzerland Jun leading indicator - KOF is out at 8:00 BST, followed by Germany Jun unemployment rate at 9:00 BST and Italy Jun prelim CPI at 10:00 BST. German Jun prelim CPI i sout at 13:00 BST.

  • Macro/ Politics/World News:

    • UK:

      • Jun shop price inflation +1.2% y/y vs consensus +1.3% and prior +1.2% - BRC

      • Business confidence falls but UK firms with international outlook remain more optimistic - Lloyds Business Barometer

      • Long-delayed defence spending plan with £5B for drones to be published -- BBC

      • Scottish Power Calls On Regulator To Securitise Bad UK Energy Debts - FT

    • France:

      • Jordan Bardella allies plan to soften Marine Le Pen's pension promise -- Politico

    • Central Banks:

      • Lagarde says Europe is getting more resilient to economic shocks -- Bloomberg

      • Surprisingly quick oil price retreat eases urgency for ECB to act, sources say -- Reuters

    • Trade:

      • EU and China seek to head off trade war with new dialogue -- Politico

  • Top company news

    • Earnings/updates

      • MAERSK.B.DC (Maersk) -- guides FY26 EBIT $2B-$4B vs prior guidance ($1.5B)-$1.0B and FactSet $779.9M [22 est, ($2.60)-2.62B]

      • MOWI.NO (Mowi) -- to sell 9k GWT salmon farming operations in Canada East to Cooke Inc. for C$225M (~€140M)

      • BOOZT.SS (Boozt Fashion) -- reports preliminary Q2 ad EBIT margin 6.5% vs year-ago 3.5%; raises FY guidance

      • MUX.GR (Mutares SE & Co KGaA) -- announces Bafin completes audit of the Financial Statements 2023

    • M&A

      • CRI.FP (Compagnie Chargeurs Invest) -- acquires Harwanne Capital Management for an undisclosed sum

      • GIMB.BB (Gimv) -- sells its stake in AlpenBlu Clinics to Impact Healthcare; terms undisclosed

      • BVI.FP (Bureau Veritas) -- to sell Oil & Petrochemicals and Coal Testing and Inspection business for EV of €470M

      • MUX.GR (Mutares) -- Amaneos completes acquisition of European Automotive Lighting Business from Magna

      • MOH.GA (Motor Oil (Hellas) Corinth Refineries) -- Aktor submits an expression of interest for the acquisition of a 75% stake in HELECTOR and THALIS E.S.; enter into exclusive negotiations with Motor Oil

      • DTE.GR (Deutsche Telekom) -- CEO Timotheus Höttges pushing to unite company with T-Mobile US - Handelsblatt

      • MOWI.NO (Mowi) -- to sell 9k GWT salmon farming operations in Canada East to Cooke Inc. for C$225M (~€140M)

      • EQT.SS (EQT) -- completes acquisition of 100% stake in DOUZONE BIZON ( 012510.KS)

      • ZAL.NO (Zalaris) -- announces acceptances received under the mandatory offer by Kona BidCo as to acquire all shares of the company

    • Healthcare

      • ABBV.SW (AbbVie) -- announces Phase 3 results met primary endpoint for epcoritamab plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

      • SAN.FP (Sanofi) -- Sanofi's Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study

      • ROP.SW (Roche Holding) -- announces FDA has accepted and granted priority review to supplemental Biologics License Application for Enspryng (satralizumab) for the treatment of thyroid eye disease

      • ARQT (Arcutis Biotherapeutics) -- FDA approves Arcutis Biotherapeutics' sNDA to expand indication for ZORYVE (roflumilast) cream 0.3% for topical treatment of plaque psoriasis including intertriginous areas to children down to age 2

      • ABVX.FP (Abivax) -- reports ABTECT maintenance Part 2 results for Obefazimod

      • DBV.FP (DBV Technologies) -- provides BLA submission update for the VIASKIN peanut patch in children aged 4 through 7 years; working collaboratively with FDA to Optimize review process in preparation for filing; conf. call today at 17:00 ET

      • BIM.FP (bioMerieux) -- submits 510(k) to FDA for the latest versions of the BIOFIRE FILMARRAY gastrointestinal panels

      • NYXH.BB (Nyxoah) -- Transcript Intelligence: Nyxoah Non Deal Roadshow

      • ORNBV.FH (Orion) -- Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market

      • IBAB.BB (Ion Beam Applications) -- wins contract for two IBA ProteusONE solutions on Portugal

    • Other

      • +INFRA.SW (Infracore SA) -- launches IPO on SIX Swiss Exchange at fixed price of CHF 54.00/sh; first trading day is expected to be on or around 9-Jul-26

      • CRNO.B.SS (Cereno Scientific) -- carries out directed share issue of SEK 60M at a premium to the latest closing price

      • HAFNI.NO (Hafnia) -- announces planned CEO succession; Mikael Skov to step down effective 1-Sep-26; Søren Steenberg Jensen appointed to succeed Skov

      • DEC.FP (JCDecaux) -- renews Heathrow advertising contract for 8 years

      • PRS.SM (Promotora de Informaciones) -- shareholders approve proposed reverse stock split; split to become effective on 10-Jul

      • KTN.GR (Kontron) -- wins major infrastructure contract in Belgium in the double-digit million range

      • ELUX.B.SS (Electrolux) -- Group submits claims related to refund of IEEPA tariffs of ~$88M

      • 1COV.GR (Covestro) -- plans to invest in new world-scale MDI train in China and starts UAE feasibility study

      • ISP.IM (Intesa Sanpaolo) -- to launch €2.3B share buyback program on 6-July

      • VK.FP (Vallourec) -- awarded major contract by AZULE energy for the greater PAJ offshore development in Angola

  • Key rating changes

    • Upgrades

      • ASKER.SS (Asker Healthcare Group) -- to buy from hold at SEB

      • ASML.NA (ASML Holding) -- to buy from hold at Degroof

      • YAR.NO (Yara International) -- to buy from hold at ABG Sundal Collier

    • Downgrades

      • SOBI.SS (Swedish Orphan Biovitrum) -- to hold from buy at Pareto

      • EZJ.LN (EasyJet) -- to neutral from buy at Citi; to neutral from buy at UBS; to sector perform from outperform at RBC Capital Markets

      • ACS.SM (ACS SA) -- to hold from buy at Bestinver Securities

      • MNDI.LN (Mondi) -- to neutral from buy at UBS

      • ESSITY.B.SS (Essity) -- to sell from hold at Sparebank 1 Markets

      • G.IM (Assicurazioni Generali) -- to market perform from outperform at Keefe, Bruyette & Woods

      • ALIF.B.SS (AddLife) -- to hold from buy at SEB

      • BRAV.SS (Bravida Holding) -- to hold from buy at Handelsbanken

      • Austevoll Seafood (AUSS.NO NOK80.80) downgraded to hold from buy; target cut to NOK89 from NOK103, 10% upside (FactSet average target NOK103.50; range NOK95-115)

      • LSG.NO (Lerøy Seafood Group) -- to hold from buy at Pareto

      • MAS.NO (Måsøval) -- to hold from buy at Pareto

      • MOWI.NO (Mowi) -- to hold from buy at Pareto

      • SALM.NO (Salmar) -- to hold from buy at Pareto

    • Initiations

      • HFG.LN (Hilton Food Group) -- hold at Kepler Cheuvreux

      • WRT1V.FH (Wartsila) -- buy at Sparebank 1 Markets

      • ALFA.SS (Alfa Laval) -- neutral at Sparebank 1 Markets

  • Data:

    • Nikkei +1.49% to 70500.81

    • Hang Seng (1.17%) to 22756.72

    • Shanghai Composite +0.12% to 4078.73

    • S&P futures +7.8 vs prior close of 7500.3

    • €-$ (0.0036) or (0.32%) to 1.1387

    • $-¥ +0.35 or +0.21% to 162.29

    • €-¥ (0.23) or (0.12%) to 184.75

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.